Xencor, Inc. (XNCR) Financials
XNCR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 952.7 million | 283.6 million |
2023-09-30 | 778.4 million | 109.4 million |
2023-06-30 | 778.1 million | 99.2 million |
2023-03-31 | 803.4 million | 119.8 million |
XNCR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 179.5 million | 14.7 million |
2023-09-30 | -30.7 million | 12.9 million |
2023-06-30 | -43.1 million | 13.6 million |
2023-03-31 | -41.8 million | 12.6 million |
XNCR Net Income
No data available :(
XNCR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 593.7 million | - | 62.5 million |
2023-09-30 | 494.5 million | - | 60.8 million |
2023-06-30 | 551.4 million | - | 58.8 million |
2023-03-31 | 588.0 million | - | 59.2 million |
XNCR Shares Outstanding
XNCR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.7 million | 63.0 million | 15.5 million | -3.4 million |
2023-09-30 | 3.4 million | 64.9 million | 12.5 million | - |
2023-06-30 | 4.9 million | 60.1 million | 11.5 million | - |
2023-03-31 | 11.2 million | 64.4 million | 13.9 million | - |
XNCR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 44.7 million | 3.2 million |
2023-09-30 | 59.2 million | 3.1 million |
2023-06-30 | 45.5 million | 2.9 million |
2023-03-31 | 19.0 million | 2.2 million |
XNCR
Price: $24.11
52 week price:
Earnings Per Share: -2.08 USD
P/E Ratio: -9.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 500400
Ebitda: -14.8 millionMarket Capitalization: 1.3 billion